Sargramostim Use in COVID-19 to Recover Patient Health
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to understand if the study drug, also called sargramostim or
Leukine®, can help prevent the worsening of COVID-19 when the study drug is inhaled. This
study will also help researchers understand if inhaled sargramostim can help prevent visits
to the emergency room or hospitalization, or death.